OHSU COVID-19 Funding Alerts: Week of April 2, 2020

OHSU Research and Innovation is compiling a running list of COVID-19 research opportunities. We will publish the list every Thursday. A pdf of the list is also available.

Internal  

ONPRC COVID-19 Pilot Grant Research Program
What: Supports short-term projects using nonhuman primate models to investigate important aspects of COVID-19 virology and pathology; all activities related to the use of NHPs must be conducted onsite at ONPRC
Who should apply: ONPRC Core Scientists and non-Core Scientists if an ONPRC Core Scientist is involved in the planning, execution and supervision and assumes responsibility for overall management, coordination and progress reports
Award: Up to $75,000/one year
Deadline: April 10, 2020, 5 p.m. PDT

New this week!
OCTRI Biomedical Innovation Program
COVID-19 Rapid Response
What: Supports proposals for basic or clinical research across the translational spectrum that directly addresses COVID-19 from all disciplines
Who should apply: Researchers who meet OHSU PI requirements
Award: Up to $75,000/average of six months
Deadline: April 23, 2020

NIH 

Parent Announcements
PA-18-935 Multiple NIH Organizations
Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement –  Clinical Trial Optional)
What: FOA to submit applications for urgent competitive revisions; intended to provide funds for NIH grantees applying to expand the scope of their active grant
Who should apply: Anyone with an active grant from one of the participating organizations who can accomplish their research within the competitive segment of the active award
Award: No minimum or maximum/within duration of the parent award
Deadline: Open dates vary by awarding IC

PA-20-135 Multiple NIH Organizations
Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement – Clinical Trial Optional)
What: : FOA to submit applications for emergency competitive revisions; offers NIH grantees additional funds for research responsive to the 2019-nCoV outbreak that falls within the scope of an ongoing grant
Who should apply: Anyone with an active grant from one of the participating organizations, such as the NIAID, who can accomplish their research within the competitive segment of the active award
Award: No minimum or maximum/within duration of the parent award
Deadline: Open dates vary by awarding IC

Updated this week!
Applies to PA-18-935
NHGRI
NOSI regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus;
NHLBI
NOSI: Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19);
NIA and NIMH NOSI: NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19);
NIDA NOSI regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus
NIGMS
NOSI regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2;
What: Offers competitive revisions to either active parent grants to expand the scope to address research objectives listed in the notice
Who should apply: Anyone with an active grant from the listed agencies
Award: Dependent upon agency
Deadline: NHGRI: Open through May 15, 2020; NHLBI: Open through Oct. 5, 2020; NIA and NIMH: Open through May 1, 2021; NIDA: Open through March 31, 2021; NIGMS: Open through Feb. 6, 2021

Applies to PA-20-135
NIAID
NOSI regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
What: Offers competitive revisions to NIAID grants for projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeutics against SARS-CoV-2/COVID-19
Who should apply: Anyone with an active grant from the NIAID
Award: No minimum or maximum/within duration of the parent award
Deadline: Open on a rolling basis through March 25, 2021

Other Notices of Special Interest
NCATS
NOSI: Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need
What: Solicits applications for Administrative Supplements to UL1, U01, and R21 awards (through PA-18-591), Collaborative Innovation Awards to U01 and R21 awards (through PAR-19-099 and PAR-19-100, respectively), and Competitive Revisions for UL1 awards for each of the non-administrative supplement awards (through PAR-19-337)
Who should apply: Anyone with an active grant with an activity code listed above from the NCATS
Award: Dependent upon FOA you apply through
Deadline: Dependent upon FOA you apply through

NCATS NOSI: Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19)
What: Supports projects that repurpose existing drugs or biologics (existing therapeutics) that have already begun or completed a Phase I clinical trial to study SARS-CoV-2 and COVID-19
Who should apply: Specific eligibility not listed
Award: Dependent upon FOA you apply through
Deadline: Dependent upon FOA you apply through

New this week!
NIAID
NOSI: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
What: Supports projects focusing on viral natural history, pathogenicity and transmission as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeutics against SARS-CoV-2/COVID-19
Who should apply: Specific eligibility not listed
Award: Dependent upon FOA you apply through
Deadline: Applies to due dates on or after April 5, 2020 and subsequent receipt dates through April 5, 2021

Notices of Intent
New this week!
AHRQ
New Funding Opportunity Announcement to Support Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19
What: Announcement of AHRQ’s intent to use the R01 mechanism to support novel, high-impact studies evaluating health system and healthcare professional responsiveness to COVID-19
Who should apply: Eligibility not listed
Award: Up to $5 million total dedicated to awards; number of awards not specified
Deadline: Estimated to be June 2020

New this week!
AHRQ
Revision Supplements to Existing AHRQ Grants and Cooperative Agreements to Address Health System Responsiveness to COVID-19
What: Announcement of AHRQ’s intent to publish a new funding notice allowing requests for urgent revision supplements to existing AHRQ grants and cooperative agreements to address health system responsiveness to COVID-19
Who should apply: Researchers with active AHRQ grants
Award: At least $2.5 million total dedicated to awards; number of awards not specified
Deadline: Estimated to be mid-May 2020
 

Other Federal Organizations 

BARDA
Division of Research, Innovation & Ventures (DRIVe)
Broad Agency Announcement
What: All of BARDA’s broad agency announcements are now focused solely on COVID-19 research; this particular mechanism focuses on diagnostic assays, screening and model development, vaccines and advanced manufacturing
Who should apply: Anyone with a research focus on the topics listed above
Award: Up to $750,000
Deadline: June 30, 2020, 2 p.m. PDT

BARDA
Broad Agency Announcement
What: All of BARDA’s broad agency announcements are now focused solely on COVID-19 research; this particular mechanism focuses on product development of solutions to the pandemic
Who should apply: Anyone with a research focus on products for prevention, diagnosis and treatment
Award: No minimum or maximum
Deadline: Open on a rolling basis through Oct. 31, 2020

CDC
CDC
Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nations Health
What: Supplemental funding for anyone receiving a grant under this parent announcement; enables recipients to provide capacity-building assistance activities in support of COVID-19 preparedness and response efforts
Who should apply: Organizations that received funding under Funding Strategy 1 of CDC-RFA-OT18-1802 in 2018
Award: No minimum or maximum
Deadline: April 2, 2020, 8:59 p.m. PDT

Medical CBRN Defense Consortium
MCDC
Other Transaction Agreement (OTA) Request for Information (RFI) – CoV Pandemic Response
What: Requests information via White Papers from both MCDC members and other interested industry/academia partners in response to the novel Coronavirus pandemic in the United States
Who should apply: Offerors were strongly encouraged to submit within 48 hours of the issue date, which was March 19, 2020; however, RFI is open, and submissions will be accepted through the end date
Award: Not specified
Deadline: May 31, 2020

New this week!
Medical Technology Enterprise Consortium
MTEC
20-09-COVID-19_Treatment_MIDRP “Development of Treatments for COVID-19”
What: Funding to find therapeutic(s) that can treat COVID-19; treatments with potential application to the prevention of COVID-19 infection and therapeutics that can be administered in a non-hospital environment are desired
Who should apply: MTEC membership is not required to apply but is required to be awarded
Award: Approximately up to $4 million/eight months
Deadline: April 8, 2020, 9 a.m. PDT

NSF
New this week!

NSF Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19)

What: Calls for proposals to conduct non-medical, non-clinical-care research that can be used immediately to explore how to model and understand the spread of COVID-19; apply through existing funding opportunities and the  Rapid Response Research funding mechanism
Who should apply: No specific eligibility guidelines; direct proposals either to a program officer managing an NSF program with which the research would be aligned or to rapid-covid19@nsf.gov
Award: Up to $200,000/up to one year for RAPID proposals
Deadline: Open

NSF Rapid Response Research (RAPID)  Funding Mechanism
What: Proposal used when there is a severe urgency with regard to availability of or access to data, facilities or specialized equipment, including quick-response research on natural or anthropogenic disasters and similar unanticipated events
Who should apply: No specific eligibility guidelines; direct proposals either to a program officer managing an NSF program with which the research would be aligned or to rapid-covid19@nsf.gov
Award: Up to $200,000/up to one year
Deadline: Open

Private Organizations

American Heart Association AHA Rapid Response Grant COVID-19 and Its Cardiovascular Impact
What: Supports research on the cardiovascular and cerebrovascular pathogenesis, diagnosis, prevention, clinical manifestations, clinical management (including critical care management) and social behaviors which can lead to dissemination, containment and complications of COVID-19
Who should apply: Anyone with a cardiovascular research background
Award: Up to $100,000/up to one year; additional funds up to $150,000 will be available to organization chosen as the  COVID-19 Coordinating Center
Deadline: April 6, 2020, 3 p.m. PDT

New this week!
LifeArc
Funding available for the development and testing of therapeutics to treat COVID-19
What: Calls for academics, NHS employees or companies that have therapeutics that could be repurposed or repositioned for use in COVID-19 patients (British organization)
Who should apply: Academics from any geographical location
Award: Approximately $1.24 million/up to one year
Deadline: April 6, 2020

New this week!
British Society for Antimicrobial Chemotherapy
COVID-19 Funding Call
What: Supports researchers in better understanding and addressing COVID-19 outbreak
Who should apply: Open worldwide to all organizations
Award: Approximately $30,980/duration not specified
Deadline: April 17, 2020

New this week!
Coalition for Epidemic Preparedness Innovation
Expression of Interest: Sponsor and CRO for clinical trials with COVID-19 candidate vaccines
What: Request for information from entities able to serve as possible sponsors or to provide operational trial support (Clinical Research Organizations) for clinical trials involving vaccine candidates against COVID-19
Who should apply: Non-profit or for-profit organizations, product development partnerships, government research organizations or intergovernmental organizations
Award: Not specified
Deadline: April 19, 2020, 6 a.m. PDT

MIT Solve
Health Security and Pandemics Challenge
What: Funds tech innovations that can slow and track the spread of an emerging outbreak such as improving individual hygiene, developing low-cost rapid diagnostics, analyzing data that informs decision making and providing tools that protect health workers
Who should apply: Anyone with a tech solution to pandemic-related issues
Award: $10,000/up to one year; duration not specified
Deadline: June 18, 2020, 9 p.m. PDT

New this week!
Amazon Web Services
Diagnostic Development Initiative
What: support for innovation in rapid and accurate patient testing for COVID-19 and other diagnostic solutions to mitigate future outbreaks
Who should apply: Open to accredited research institutions
Award: $20 million in total funding for all projects; funding will be provided through a combination of AWS in-kind credits and technical support
Deadline: June 30, 2020

Leave a Reply